PDR BY CONNECTIVERX - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Serial Number
90513825
Word Mark
PDR BY CONNECTIVERX
Status
661 - Response After Non-Final Action - Entered
Status Date
2022-01-20
Filing Date
2021-02-05
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Attorney Name
Law Office Assigned Location Code
O10
Employee Name
OAKES, JEFFREY ALLEN
Statements
Description of Mark
The mark consists of the letters "PDR" in bold capital font to the left of the term "BY" in italicized lowercase font, all the aforesaid appearing over the term "CONNECTIVERX" in which the letters "C" and "R" are capitalized.
Goods and Services
Providing medical information and healthcare information regarding physical health, mental health, and prescription medications via website, mobile app, electronic health record systems, and email
Pseudo Mark
PDR BY CONNECTIVE RX
Classification Information
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-05-11
Primary Code
044
First Use Anywhere Date
2018-05-05
First Use In Commerce Date
2018-05-05
Current Trademark Owners
Correspondences
Name
KIRK A. DAMMAN
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2021-02-09 | NEW APPLICATION ENTERED IN TRAM |
| 2021-05-11 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-08-29 | ASSIGNED TO EXAMINER |
| 2021-08-30 | NON-FINAL ACTION WRITTEN |
| 2021-08-30 | NON-FINAL ACTION E-MAILED |
| 2021-08-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2022-01-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2022-01-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2022-01-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
